Tripathi KD. Sulfonamides, cotrimoxazole and quinolones. In: Essentials of Medical Pharmacology. 7th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd.; 2013. p. 708-13.
Kale RS, Awari BN, Chakraborty D, Bahekar SE. Levofloxacin-induced bullous fixed drug eruption: A rare case report. Indian J Health Sci 2016; 9: 111-3.
Ravishankar M, Deepika G, Shwetha S. Ciprofloxacin induced fixed drug eruption. Int J Basic Clin Pharmacol 2014; 3: 1096-7.
Pal A, Sen S, Das S, Biswas A, Tripathi SK. A case of self-treatment induced recurrent fixed drug eruptions associated with the use of different fixed dose combinations of fluoroquinolone-nitroimidazole. Iran J Med Sci 2014; 39(6): 584.
Wilton L, Pearce G, Mann R. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol 1996; 41: 277-84.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-45.
Valeyrie-allanore L, Sassolas B, Roujeau JC. Drug induced skin, nail, hair disorders. Drug Saf 2007; 30: 1011-30.
Nair PA. Ciprofloxacin induced bullous fixed drug reaction: Three case reports. J Family Med Prim Care 2015; 4(2): 269.
Fernandez-Rivas M. Fixed drug eruption (FDE) caused by norfloxacin. Allergy 1997; 52(4): 477-8.
S Patel N. C Chavada B, N Naik V, N Patel H, B Tripathi C. Metronidazole and Norfloxacin induced generalized fixed drug eruptions in an adult male patient-a case report. Curr Drug Saf 2017; 12(2): 120-2.
Machida M, Kusajima H, Aijima H, Maeda A, Ishida R, Uchida H. Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. Toxicol Appl Pharmacol 1990; 105(3): 403-12.
Neki NS. Hallucinations secondary to norfloxacin-a case report. JIMSA 2010; 23: 241.
Adikwu E, Deo O. Fluoroquinolones reported hepatotoxicity. Pharmacol Pharm 2012; 3(03): 328.
Sarro AD, Sarro GD. Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr Med Chem 2001; 8(4): 371-84.
Aboubakr M, Elbadawy M, Soliman A, El-Hewaity M. Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats Adv Pharmacol Sci 2014; 2014.
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Health Syst Pharm 1992; 49(9): 2229-32.
Lau PM, Stewart K, Dooley MJ. Comment: Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2003; 37(2): 303-4.
Demissew BH, Wubeante YA, Pramil T. Prevalence and assessment of factors contributing to the adverse drugs reactions in the wards of a tertiary care hospital, India. Ethiop J Health Sci 2013; 23(1): 39-48.
Bennadi D. Self-medication: A current challenge. J Basic Clin Pharm 2013; 5(1): 19.